california require aspirin makers women against taking stages pregnancy state science panel decided panel friday classified aspirin reproductive toxin under proposition landmark toxics initiative requires public warnings substances cancer birth defects warnings probably aspirin labels appear within after substance formally listed keeping panel decision making recommendation panel rejected report prepared aspirin industry report found evidence aspirin taken three months pregnancy could cause excessive bleeding during delivery other pregnancy complications panel unanimously ruled risks shown based studies involving aspirin dosage panel members acknowledged recent studies aspirin doses tablet relieve certain medical problems suffered pregnant women aspirin warning should qualified advise women against taking aspirin three months pregnancy unless directed doctor aspirin products carried general warning label since certain over-the-counter aspirin substitutes carry label reads especially important aspirin during three months pregnancy unless specifically directed doctor because cause problems unborn child complications during delivery proposition mandates public warnings dictate warning labels specific products however spokesman aspirin industry warning label seemed likely about administration notified state authorities planned require warning over-the-counter aspirin products similar warning under review proposition panel science panel members point waiting federal action aspirin industry representatives pushed action proposition which served model toxics legislation across country
